Larimar Therapeutics Inc (LRMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Operating Expenses | 8,687 | 8,887 | 9,086 | 16,730 | 12,543 |
| Operating Income | -8,687 | -8,887 | -9,086 | -16,730 | -12,543 |
| Other Income | 20 | -56 | -48 | -75 | -66 |
| Pre-tax Income | -8,667 | -8,943 | -9,134 | -16,805 | -12,609 |
| Net Income Continuous | -8,667 | -8,943 | -9,134 | -16,805 | -12,609 |
| Net Income | $-8,667 | $-8,943 | $-9,134 | $-16,805 | $-12,609 |
| EPS Basic Total Ops | -0.47 | -0.49 | -0.48 | -0.92 | -0.79 |
| EPS Basic Continuous Ops | -0.47 | -0.49 | -0.49 | -0.92 | -0.79 |
| EPS Diluted Total Ops | -0.47 | -0.49 | -0.48 | -0.92 | -0.79 |
| EPS Diluted Continuous Ops | -0.47 | -0.49 | -0.49 | -0.92 | -0.79 |
| EBITDA(a) | $-8,609 | $-8,805 | $-9,000 | $-16,643 | $-12,472 |